TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.

Lagos, led by Professor Kingsley Ekwueme, has pioneered high-intensity focused ultrasound (HIFU) for prostate cancer treatment, positioning Nigeria as the first nation in West and Central Africa to ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

Department of Urology, All India Institute of Medical Sciences (AIIMS) Jammu, has commenced advanced endourological services, ...

A 75-year-old artist living in Guatemala, identified as Freed III, traveled to Vietnam to receive treatment for a severely enlarged prostate after years of persistent symptoms and unsuccessful medical ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

Profound would also like to congratulate Satoru Takahashi, MD, PhD, of Takatsuki General Hospital in Japan, for receiving a Certificate of Merit award from RSNA for his presentation titled “TULSA for ...

Abstract: We seek to enable transurethral focal resection of prostate tumors via enhanced robotic dexterity, combined with MRI image guidance. Our approach is designed to reduce invasiveness compared ...

BENIGN prostatic hyperplasia (BPH) is a common cause of lower urinary tract symptoms (LUTS) in middle-aged and older men. While transurethral resection of the prostate (TURP) remains the gold standard ...

TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, ...